Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03816345
Title Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

stomach cancer

Hodgkin's lymphoma

lung non-small cell carcinoma


renal cell carcinoma

lung small cell carcinoma

urinary bladder cancer

head and neck cancer

hepatocellular carcinoma

Merkel cell carcinoma

cervical cancer

Advanced Solid Tumor



Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.